Related Experiment Video
Updated: May 15, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44
Haien Zhao1, Baoan Ma, Yucai Wang
1Department of Orthopaedic Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710038, PR China.
Abstract:
Osteosarcoma is the most common type of malignant bone tumor in children and adolescents and approximately 30% of patients develop lung metastasis, which is the leading cause of mortality. In this study, we investigated the role of miR-34a in the invasion and metastasis of osteosarcoma cells by examining its expression level and functional pattern in these cells. miR-34a mimics were transfected into the highly metastatic subline, F5M2, and into the F4 subline with low metastatic potential of the paired human osteosarcoma cell line, SOSP‑9607. Cell viability patterns, cell migration and alterations in gene expression levels were assessed by real-time PCR, and changes in protein levels were assessed by immunocytochemistry and western blot analysis. The ectopic overexpression of miR-34a significantly inhibited the migration and invasive ability of osteosarcoma cells by repressing the expression of CD44. These data suggest that miR-34a plays a tumor suppressor role in the metastasis of osteosarcoma cells by repressing the expression of CD44. Of note, studies have also suggested that the CD44 protein correlates with the metastatic potential of several malignant tumors. Therefore, it can be concluded that through the inhibition of CD44 expression levels, miR-34a plays a significant role in the migration and invasion of osteosarcoma cells.
Insights
MicroRNA-34a (miR-34a) acts as a tumor suppressor in osteosarcoma metastasis. It inhibits cancer cell invasion and migration by downregulating CD44 expression, a protein linked to tumor spread.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Osteosarcoma is a common pediatric bone cancer with high mortality due to lung metastasis.
- MicroRNAs (miRNAs) are implicated in cancer progression, but their specific roles in osteosarcoma metastasis require further elucidation.
Purpose of the Study:
- To investigate the role of microRNA-34a (miR-34a) in the invasion and metastasis of osteosarcoma cells.
- To examine the functional impact of miR-34a on osteosarcoma cell behavior and its potential targets.
Main Methods:
- Transfection of miR-34a mimics into human osteosarcoma cell lines (SOSP-9607 F5M2 and F4).
- Assessment of cell viability, migration, and invasion using real-time PCR, immunocytochemistry, and Western blot analysis.
- Evaluation of gene and protein expression levels, focusing on CD44.
Main Results:
- Ectopic overexpression of miR-34a significantly inhibited osteosarcoma cell migration and invasion.
- miR-34a exerted its inhibitory effect by repressing the expression of CD44.
- CD44 protein levels were found to correlate with the metastatic potential of osteosarcoma cells.
Conclusions:
- miR-34a functions as a tumor suppressor in osteosarcoma metastasis.
- The tumor-suppressive role of miR-34a is mediated through the repression of CD44 expression.
- Targeting miR-34a or CD44 may offer therapeutic strategies for preventing osteosarcoma metastasis.
More Related Videos
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
MicroRNAs
MicroRNAs

